Clinical Trial: Ketamine Tolerated Dose to Prevent Postpartum Depression and Pain After Cesarean Delivery
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Pain, Postoperative
Study Type: INTERVENTIONAL
Official Title: Ketamine Tolerated Dose to Prevent Postpartum Depression and Pain After Cesarean (PREPARE1)
Brief Summary:
The purpose of this study is to identify a tolerable dose for postpartum ketamine infusion using a maximum tolerated dose (MTD) 3+3 design.A loading dose over 1 hour will be the MTD variable to be tested, as our data suggest that ketamine side effects occur with the loading dose.The subanesthetic ketamine dose will be well tolerated and noted side effects will be acceptable by postpartum women following cesarean delivery.
Read more